Published in Surgery on October 01, 1974
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib. World J Surg Oncol (2012) 0.84
Solitary metachronous splenic metastasis from cutaneous melanoma. BMJ Case Rep (2012) 0.75
Pancreatic adenosquamous carcinoma presenting as splenic rupture: report of a case. Surg Today (2011) 0.75
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg (1993) 2.08
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Metastatic patterns in soft-tissue sarcomas. Arch Surg (1983) 1.66
Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res (1986) 1.55
Desmoid tumour: a pleomorphic lesion. Eur J Surg Oncol (1999) 1.54
Leiomyosarcoma of the inferior vena cava: a clinicopathologic review and report of three cases. J Surg Oncol (1997) 1.46
Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck (1992) 1.46
Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med (1981) 1.45
Desmoid tumors in patients with familial adenomatous polyposis. Cancer (1994) 1.44
What is a surgical oncologist? Ann Surg Oncol (1994) 1.40
Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer (1981) 1.40
Survival in metastatic ocular melanoma. Cancer (1983) 1.37
Intravenous leiomyomatosis with cardiac extension: tumor thrombectomy through an abdominal approach. J Vasc Surg (2000) 1.35
Metastatic carcinomas from occult primary tumors. A study of 254 patients. Ann Surg (1977) 1.34
Prognostic value of lymph node dissection in malignant melanoma. Arch Surg (1980) 1.24
Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer (1992) 1.18
Cytogenetic profile of 109 lipomas. Cancer Res (1991) 1.18
Desmoid tumors and their management. Am J Surg (1985) 1.15
Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma. Dis Colon Rectum (1974) 1.15
Prognostic significance of lymph node metastasis and bone, major vessel, or nerve involvement in adults with high-grade soft tissue sarcomas. Cancer (1988) 1.13
Malignant soft tissue tumors of nerve sheath origin. J Surg Oncol (1984) 1.13
Complications and outcome of external hemipelvectomy in the management of pelvic tumors. Ann Surg Oncol (1996) 1.12
Renal toxicity in man treated with mitomycin C. Cancer (1971) 1.11
Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet (1989) 1.10
Liposarcomas: prognosis and management. J Surg Oncol (1980) 1.09
A clinicopathologic study of prognostic factors in cutaneous malignant melanoma. Surg Gynecol Obstet (1977) 1.09
Evaluation of palliative resection in advanced carcinoma of the stomach. Surgery (1975) 1.08
A prospective randomized study of sutured versus stapled bowel anastomoses in patients with cancer. Cancer (1986) 1.08
Carcinoma of the colon, rectum, and anal canal in young patients. Surg Gynecol Obstet (1974) 1.07
Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trial. Cancer (1985) 1.07
Mithramycin in the treatment of Paget's disease of bone. J Bone Joint Surg Am (1972) 1.05
Anorectal melanoma: clinical features, recurrence and patient survival. Int Surg (1981) 1.04
Richter hernia of the stomach. J Surg Oncol (1998) 1.02
Ths significance of metastases to the adrenal glands in adenocarcinoma of the colon and rectum. Surg Gynecol Obstet (1977) 1.02
Pyomyositis: a differential diagnosis from sarcoma. J Surg Oncol (1985) 1.02
The surgical treatment and outcome of soft-tissue sarcoma. Arch Surg (1981) 1.01
Distant skin and soft tissue metastases from sarcomas. J Surg Oncol (1998) 1.01
Gastrointestinal metastases from malignant melanoma. Surg Oncol (1995) 1.01
Symptomatic gastrointestinal metastases from malignant melanoma. Cancer (1981) 1.00
Intraoperative photodynamic therapy for retroperitoneal sarcomas. Cancer (1988) 1.00
Primary malignant tumors of the small intestine. Surg Gynecol Obstet (1976) 1.00
Treatment of unknown primary melanoma. Cancer (1991) 0.99
Management of retroperitoneal sarcomas and patient survival. Am J Surg (1985) 0.99
Partial and complete internal hemipelvectomy: complications and long-term follow-up. J Am Coll Surg (1995) 0.99
The technique of popliteal lymph node dissection. Surg Gynecol Obstet (1980) 0.98
Primary malignant tumors of the upper extremity: retrospective analysis of one hundred twenty-six cases. J Hand Surg Am (1985) 0.96
Eccrine porocarcinoma. J Surg Oncol (1994) 0.95
Variants of hemipelvectomy. Am J Surg (1983) 0.95
The effect of local recurrence on survival time in adult high-grade soft tissue sarcomas. J Clin Epidemiol (1989) 0.94
Extraosseous multiple myeloma: a cause of intestinal obstruction. Ann Surg (1969) 0.93
Malignant melanoma of the gallbladder: report of a case and review of the literature. Am Surg (1995) 0.93
Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. Eur J Surg Oncol (2001) 0.92
Heparin and chemotherapy in the management of inoperable lung carcinoma. Cancer (1975) 0.92
Primary neoplasms of the duodenum. Surg Gynecol Obstet (1976) 0.91
The significance of metastases to the adrenal gland from carcinoma of the stomach and esophagus. Surg Gynecol Obstet (1977) 0.91
Estrogen and progesterone receptors and tamoxifen in malignant melanoma. Cancer Treat Rep (1981) 0.91
Mesenteric fibromatosis in Gardner's syndrome. Arch Surg (1978) 0.90
Attributes and survival patterns of multiple primary cutaneous malignant melanoma. Cancer (1991) 0.90
Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver. Cancer Res (1987) 0.90
Feasibility of limb salvage and survival in soft tissue sarcomas. Cancer (1986) 0.90
Subungual melanoma: an eighteen-year review. Surgery (1994) 0.90
Cellular immunity in patients with colorectal adenocarcinoma measured by autologous leukocyte migration inhibition. Cancer (1977) 0.89
Blood groups and malignant melanoma. J Surg Oncol (1986) 0.88
Hilar hepatojejunostomy in resection of carcinoma of the main hepatic duct junction. Surg Gynecol Obstet (1977) 0.88
Prognostic parameters in recurrent malignant melanoma. Cancer (1983) 0.88
Malignant melanoma of the anorectal region. J Surg Oncol (1995) 0.88
Various types of hemipelvectomy for soft tissue sarcomas: complications, survival and prognostic factors. Surg Oncol (1995) 0.87
Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen. Cancer (1979) 0.87
Gastrocolic fistula as a complication of benign gastric ulcer. Arch Surg (1979) 0.87
Abdominal wall replacement with plastic mesh in ablative cancer surgery. Surgery (1975) 0.86
Tumor size/symptom duration ratio as a prognostic factor in patients with high-grade soft tissue sarcomas. Eur J Cancer Clin Oncol (1988) 0.86
Prognostic factors in squamous cell carcinoma of the larynx. Am J Surg (1989) 0.86
Clinical factors and treatment parameters affecting prognosis in adult high-grade soft tissue sarcomas: a retrospective review of 267 cases. Eur J Surg Oncol (1989) 0.86
Biologic behavior and treatment of intransit metastasis of melanoma. Surg Gynecol Obstet (1980) 0.86
Adrenal adenocarcinomas: histologic grading and survival. J Surg Oncol (1985) 0.86
Axillary node dissection in malignant melanoma. Surg Gynecol Obstet (1981) 0.85
Tourniquet infusion versus hyperthermic perfusion. Cancer (1982) 0.85
High-dose methotrexate as secondary chemotherapy in metastatic soft-tissue sarcomas. Cancer (1980) 0.84
Axillary compression syndrome with neurapraxia due to operative positioning. Surgery (1989) 0.84
Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I. Cancer (1985) 0.84
Risk of basal cell and squamous cell carcinoma in persons with prior cutaneous melanoma. Dermatol Surg (2000) 0.84
Lymphedema after groin dissection. Am J Surg (1983) 0.84
Adjuvant chemotherapy for breast cancer: an overview of NSABP findings. Int Adv Surg Oncol (1982) 0.84
Congenital absence of vermiform appendix. Arch Surg (1967) 0.84
Evaluation of forequarter amputation in malignant diseases. Surg Gynecol Obstet (1976) 0.84
Band 11q13 is nonrandomly rearranged in hibernomas. Genes Chromosomes Cancer (1994) 0.84
An institutional review of sarcomas of the large and small intestine. J Am Coll Surg (1995) 0.84
Increased prostaglandin E2 and cAMP phosphodiesterase levels in Kaposi's sarcoma--a virus against host defense mechanism. Res Commun Chem Pathol Pharmacol (1992) 0.84
cis-Dichlorodiammineplatinum(II) and DTIC in malignant melanoma. Cancer Treat Rep (1980) 0.83
Malignant melanoma of the scrotum: report of 2 cases. J Urol (1994) 0.83
Carcinoma of the pancreas. Arch Surg (1969) 0.83
Autogenous leukocyte migration in human malignancies. Cancer (1975) 0.83
Adrenal adenocarcinoma: a review of 53 cases. J Surg Oncol (1994) 0.83
Internal hemipelvectomy. Surg Gynecol Obstet (1984) 0.83
Long-term survival of a female patient with primary malignant melanoma of the urethra. Eur J Surg Oncol (1998) 0.83